Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis

Primary sclerosing cholangitis (PSC) is an autoimmune disease of the hepatobiliary system for which effective therapy has not been established. Leukocytapheresis (LCAP) therapy is known to effective in patients with ulcerative colitis (UC). In addition, effects of LCAP therapy were reported on some...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Itou, Minoru, Mitsuyama, Keiichi, Kawaguchi, Takumi, Okabe, Yoshinobu, Suga, Hideya, Masuda, Junya, Yamasaki, Hiroshi, Kuwaki, Kotaro, Taniguchi, Eitaro, Harada, Masaru, Tsuruta, Osamu, Sata, Michio
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2009
Teme:
Published: April 2009
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895181/
https://ncbi.nlm.nih.gov/pubmed/20651970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000210439
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items